Amalgamated Financial’s Integra LifeSciences IART Stock Holding History

Amalgamated Financial’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$3.23M	Buy	+50,283	New	+$3.31M	0.03%	697

Other funds holding IART

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Amalgamated Financial's IART Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Integra LifeSciences (IART) in Q1 2022: 50,283 shares worth $3.23M. The stake represents 0.03% of the portfolio and ranks #697 among its holdings.

278 funds tracked by Wall St. Rank hold IART as of Q1 2022.

Amalgamated Financial held 50,283 shares of Integra LifeSciences worth $3.23M as of Q1 2022.
Integra LifeSciences was a new Amalgamated Financial position in Q1 2022.
Integra LifeSciences made up 0.03% of Amalgamated Financial's portfolio in Q1 2022, its #697 holding.
278 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.